Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
| 351.81 Delayed Data As of Sep 26 |  +1.02 / +0.29%Today’s Change | 276.57 Today|||52-Week Range 367.00 | +21.83% Year-to-Date |
Latest VRTX News | Press Releases
Today’s Trading
| Previous close | 350.67 |
| Today’s open | 350.00 |
| Day’s range | 349.17 - 352.54 |
| Volume | 633,698 |
| Average volume (3 months) | 1,137,796 |
| Market cap | $90.2B |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +42.72% |
| Earnings growth (this year) | -2.24% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +15.04% |
| P/E ratio | 27.2 |
| Price/Sales | 8.55 |
| Price/Book | 6.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REGNRegeneron Pharmaceut... | -2.23 | -0.27% |
| ZTSZoetis Inc | +0.01 | +0.01% |
| GSKGlaxoSmithKline | +0.01 | +0.03% |
| ---- |
Data as of 4:00pm ET, 09/26/2023
Financials
| Next reporting date | November 1, 2023 |
| EPS forecast (this quarter) | $3.88 |
| Annual revenue (last year) | $8.7B |
| Annual profit (last year) | $3.3B |
| Net profit margin | 37.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
